STTK
Shattuck Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.01
+2.74%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $37.5K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$0.12
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +7.2%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $15
- PT range
- $10 – $18
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.12 | -$0.12 | Beat 3.28% | — |
| May 7, 2026 | -$0.14 | -$0.13 | Beat 7.14% | — |
| Mar 5, 2026 | -$0.14 | -$0.12 | Beat 11.87% | — |
| Nov 6, 2025 | -$0.15 | -$0.14 | Beat 6.67% | $1.0M |
| Aug 14, 2025 | -$0.25 | -$0.24 | Beat 4.00% | — |
| May 1, 2025 | -$0.29 | -$0.27 | Beat 6.90% | — |
| Mar 27, 2025 | -$0.38 | -$0.37 | Beat 2.63% | $14.5M |
| Nov 14, 2024 | -$0.41 | -$0.33 | Beat 19.51% | $3.0M |
| Aug 1, 2024 | -$0.41 | -$0.42 | Miss -2.44% | $1.6M |
| May 2, 2024 | -$0.47 | -$0.37 | Beat 21.28% | $1.1M |
| Feb 29, 2024 | -$0.51 | -$0.41 | Beat 19.61% | $714.0K |
| Nov 9, 2023 | -$0.52 | -$0.65 | Miss -25.00% | $686.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026